D-2570 in people with different kidney function
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests how a new drug, D-2570, is processed by the body in people with normal or reduced kidney function. It aims to understand if kidney function affects how the drug works, which could help guide dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- You are willing to sign a consent form and follow the study procedures.
- You weigh at least 50 kg (men) or 45 kg (women). Your body mass index (BMI) must be between 19 and 30.
- You do not have a history of allergies or conditions like asthma or hives that could increase risk.
- You do not have active tuberculosis (TB), based on a TB test and chest X-ray.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This trial tests how a drug called D-2570 is processed in people with different levels of liver function. It compares people with liver impairment to those with healthy livers to see how the drug moves through the body.
This study checks how a new medicine, D-2570, interacts with other drugs in healthy adults. It helps find the right dose and safety before it is tested in patients.
This trial tests a new oral medication called D-2570 for people with active systemic lupus erythematosus (SLE). It aims to see if the drug can help control lupus symptoms while you continue your current stable treatments.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.